Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Cytori Therapeutics Inc

+ Add to Watchlist

XMPA:GR

0.584 EUR 0.008 1.35%

As of 15:44:37 ET on 05/22/2015.

Snapshot for Cytori Therapeutics Inc (XMPA)

Open: 0.600 Day's Range: 0.580 - 0.621 Volume: 8,765
Previous Close: 0.592 52wk Range: 0.266 - 1.850 1-Yr Rtn: -64.61%

Stock Chart for XMPA

No chart data available.
  • XMPA:GR 0.604
  • 1D
  • 1M
  • 1Y
0.592
Interactive XMPA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XMPA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.2640
Est. PEG Ratio -
Market Cap (M EUR) 81.31
Shares Outstanding (M) 139.24
30 Day Average Volume 11,037
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XMPA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XMPA

Cytori Therapeutics, Inc. discovers and develops cell-based therapeutics utilizing adult stem cells derived from fat tissue. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery.

Marc H HedrickPres/CEO/Principal Financial OfcrSeijiro Norio ShirahamaPresident:Asia Pacific
Steven KestenExec VP/Chief Medical OfficerTiago GiraoVP:Finance/CFO
More Company Profile & Key Executives for XMPA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil